The objective response rate ( ORR ) and clinical benefit rate ( CBR ) were 0 and 62.5 % in the combined arm , along with 0 and 53.3 % in the single docetaxel arm , with a non-significant difference between the two groups ( all P > 0.05 ) , respectively .